Mkts

Bioventus Inc.

NASDAQ: BVS
$10.86-0.13 (-1.18%)
As of Nov 12, 4:00 PM ET

Key statistics

Day range
10.8211.19
52-week range
6.4715.89
Today
Open11.06
Previous close10.86
Volume—
Valuation
Market cap926.03M
P/E ratio17.00×
EPS (TTM)0.78
Income & risk
Dividend / yield—
Beta0.64
Avg volume615.1K
Discussion

BVS News

Stories mentioning BVS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 28Q4 '25Dec 31Q3 '25Sep 27Q2 '25Jun 28Q1 '25Mar 29Q4 '24Dec 31Q3 '24Sep 28Q2 '24Jun 29
Income Statement
Revenue132,089157,900138,651147,660123,876153,642138,964151,217
Cost of Goods Sold41,32049,11844,42245,57040,82050,98645,41347,578
Gross Profit90,769108,78294,229102,09083,056102,65693,551103,639
Operating Expenses
Research & Development2,4673,0072,9233,1723,0113,2713,8434,210
Sales General & Admin78,32582,75778,65779,11073,50286,87381,48296,668
Total Operating Expenses
Operating Income (Loss)8,41619,48611,25218,3684,8697,7033,647(31,473)
Interest Income
Interest Expense
Other Expense427.00(37.00)(79.00)(561.00)(777.00)1,241626.00(159.00)
Pretax Income4,51714,1434,67010,313(3,417)(53.00)(5,259)(41,556)
Tax Provision571.00(3,175)664.001,041(95.00)550.00589.00(7,339)
Net Income (Loss)3,11314,7553,1557,459(2,637)(388.00)(5,165)(25,682)
Earnings Per Share (Basic)0.050.220.050.11(0.04)(0.01)(0.08)(0.40)
Earnings Per Share (Diluted)0.040.210.050.11(0.04)(0.01)(0.08)(0.40)
Weighted Average Shares Outstanding (Basic)67,29666,62366,92566,50066,00964,54765,25864,057
Weighted Average Shares Outstanding (Diluted)70,00868,91568,83868,53766,00964,54765,25864,057

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BVS

Bioventus Inc. (NASDAQ: BVS) is a stock listed on the Nasdaq Stock Market under the ticker symbol BVS. It last traded at $10.86 (Nov 12, 2026, 4:00 PM ET), down 1.2% on the day. That gives Bioventus a market capitalisation of $926.0M and a price-to-earnings ratio of 17.0.

Over the past 52 weeks BVS has traded between $6.47 and $15.89.

Revenue for the quarter ended Mar 28, 2026 was $132.1M; net income $3.1M. Revenue was up 6.6% from $123.9M in the quarter ended Mar 29, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 28, 2026$132.1M$3.1M2.4%
Dec 31, 2025$157.9M$14.8M9.3%
Sep 27, 2025$138.7M$3.2M2.3%
Jun 28, 2025$147.7M$7.5M5.1%

From Bioventus’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…